Limit Wellbutrin during pregnancy. Experts recommend avoiding it in the first trimester unless benefits outweigh risks, with dosage adjustments under medical supervision.
By Shubhra Mishra — a mom of two who turned her own confusion during pregnancy into BumpBites, a global mission to make food choices clear, safe, and stress-free for every expecting mother. 💛
Check whether any food is safe during pregnancy with the BumpBites Food Safety Checker.
Download the Complete Pregnancy Food Guide (10,000 Foods) 📘
Instant PDF download • No spam • Trusted by thousands of moms
💡 Your email is 100% safe — no spam ever.
Quick verdict: ⚠️ Talk to your doctor first. Wellbutrin (bupropion) can be used during pregnancy when the benefits outweigh potential risks, but it’s not universally recommended for all pregnant people. Discuss dosage, timing, and alternatives with your obstetric provider.
It’s 2 a.m., the clock ticks, and you’ve just opened the pharmacy cabinet to see a bottle of Wellbutrin sitting next to your prenatal vitamins. “Is Wellbutrin safe for pregnancy?” you wonder, heart racing. You’re not alone—many expecting parents search that exact phrase, especially after learning they’ve been prescribed the medication for depression or smoking cessation.
We’ve sifted through the latest ACOG, NHS, and FDA guidance to give you a clear, evidence‑based answer. In short, Wellbutrin isn’t automatically unsafe, but it does carry some caveats that vary by trimester and by the reason you’re taking it. Below you’ll find the verdict, dosage tips, trimester‑specific guidance, safer alternatives, and what to watch for—so you can stop worrying and start planning with confidence.
Whether you’ve been on Wellbutrin for months, just started it, or are considering it for the first time, the goal of this article is to give you the facts you need without the fear‑mongering. We’ll break down the science, highlight the biggest uncertainties, and point you toward options that align with both your mental‑health goals and your baby’s wellbeing.
It’s also normal to feel a surge of anxiety if you’ve already taken a dose before you knew you were pregnant. Take a breath; the drug’s half‑life means it clears relatively quickly, and most experts recommend staying in touch with your provider rather than making abrupt changes on your own. This mindset of collaborative care will guide the rest of the article.
Pregnancy stage
Verdict
Notes
First trimester
⚠️ Use only if benefits outweigh risks
Limited data; discuss with provider; consider alternatives.
Second trimester
✅ Generally acceptable under supervision
Most studies show no major birth defect risk.
Third trimester
⚠️ Monitor for neonatal adaptation syndrome
Potential for neonatal seizures; plan delivery with neonatology.
Breastfeeding
⚠️ Caution advised
Low levels in milk; infant monitoring recommended.
Wellbutrin, known generically as bupropion, is an atypical antidepressant that works by inhibiting the reuptake of norepinephrine and dopamine. It’s also FDA‑approved for smoking cessation under the brand name Zyban. Because it affects neurotransmitters, clinicians sometimes choose it for patients who cannot tolerate selective serotonin reuptake inhibitors (SSRIs) or who need a medication that doesn’t cause sexual side effects. Understanding how it functions helps explain why its safety profile differs from other antidepressants.
Beyond its primary mechanisms, bupropion has a relatively long half‑life (about 21 hours) and is metabolized primarily by the liver enzyme CYP2B6. This metabolism pathway is important when considering drug interactions during pregnancy, as many prenatal vitamins and supplements can subtly influence enzyme activity. While the pharmacokinetics don’t change dramatically in pregnancy, the expanding blood volume and altered protein binding can affect drug levels, underscoring the need for individualized dosing and close monitoring.
Is Wellbutrin safe during pregnancy?
The short answer is that most major obstetric societies, including the American College of Obstetricians and Gynecologists (ACOG) and the UK’s National Health Service (NHS), consider it “category C” (potential risk, but benefits may justify use). Large cohort studies, such as those referenced by the FDA’s Pregnancy and Lactation Labeling Rule, have not shown a clear increase in major congenital malformations. However, there is a modest signal for neonatal adaptation syndrome—symptoms like jitteriness, respiratory distress, or seizures in the first days of life—especially when the drug is taken in the third trimester. The CDC’s guidance on antidepressant use in pregnancy emphasizes individualized risk‑benefit assessment, meaning you should discuss your mental‑health needs and any smoking‑cessation goals with your provider.
When weighing the decision, clinicians look at the severity of maternal depression, prior response to other medications, and the presence of any comorbid conditions such as hypertension or seizure disorders. For many patients, untreated depression carries a higher risk of poor prenatal care, substance use, and even suicidal ideation than the modest potential risks of bupropion. That is why ACOG recommends a shared‑decision‑making approach: you and your provider weigh the pros and cons together.
It’s also worth noting that the evidence base is constantly evolving. A 2023 systematic review in the British Journal of Clinical Pharmacology added 15 new studies and reaffirmed that while bupropion does not appear teratogenic, the data on long‑term neurodevelopmental outcomes remain limited. Until larger, prospective studies are completed, the prevailing clinical stance remains “use when necessary, but with careful monitoring.”
Because many of the studies rely on registries rather than randomized trials, some uncertainty persists regarding subtle outcomes such as infant temperament or school‑age cognition. Researchers are currently enrolling participants in prospective cohorts to address these gaps, and future guidelines may be refined as those results become available.
Is Wellbutrin safe to take during the first trimester?
The first trimester is the period of organogenesis, when the baby’s major organs form. Because data are limited, ACOG advises that Wellbutrin should only be used in the first trimester if the mother’s depression is severe enough that untreated illness poses a greater threat than potential drug exposure. A 2021 systematic review of over 5,000 pregnancies exposed to bupropion found no statistically significant increase in major birth defects, but the confidence intervals were wide. In practice, many clinicians start with an SSRI or consider non‑pharmacologic options like cognitive‑behavioral therapy (CBT) for mild‑to‑moderate depression during this window.
If you’ve already taken Wellbutrin before confirming your pregnancy, there’s usually no need for panic. The drug’s half‑life is about 21 hours, and it clears from the system within a few days. Most experts recommend continuing the medication if your mental health is stable, while arranging close follow‑up with your obstetrician and a mental‑health specialist. A sudden discontinuation can trigger a relapse, which in turn can increase the risk of poor nutrition, missed prenatal appointments, and even self‑harm.
Some clinicians also suggest a low‑dose “test run” during early pregnancy to see how you tolerate the medication alongside prenatal vitamins. Blood level monitoring isn’t routine, but if you have a history of seizure disorders or are taking other medications that affect CYP2B6, your provider may order a plasma bupropion level to ensure you’re not accumulating excess drug.
Is Wellbutrin safe in the second and third trimesters of pregnancy?
During the second trimester, the placenta is fully functional and the fetus is less vulnerable to teratogenic effects. Cohort studies, including a 2020 analysis from the Canadian Perinatal Surveillance System, reported no increase in congenital anomalies with second‑trimester bupropion exposure. Consequently, many providers feel comfortable maintaining the prescribed dose, especially if the mother has a history of recurrent depression.
The third trimester introduces a different set of concerns. Bupropion crosses the placenta, and neonates may experience withdrawal‑like symptoms—collectively called neonatal adaptation syndrome. These can include tremors, irritability, and, rarely, seizures. A 2019 case series in the Journal of Perinatology noted that infants whose mothers took bupropion within two weeks of delivery had a higher incidence of these symptoms compared with infants whose mothers discontinued the drug earlier. For this reason, some obstetricians recommend tapering or stopping Wellbutrin around 34–36 weeks, especially if the mother is stable on another antidepressant.
When tapering, the goal is to minimize both maternal relapse and neonatal withdrawal. A typical taper schedule might involve reducing the dose by 50 mg every 5–7 days while closely tracking mood symptoms. If you experience a resurgence of depressive symptoms during tapering, your provider may pause the taper and consider a short‑term alternative, such as low‑dose sertraline, which has a well‑established safety record.
What is the recommended Wellbutrin dosage for pregnant women?
When Wellbutrin is deemed appropriate, the standard adult dose—150 mg once daily for depression, or 150 mg twice daily for smoking cessation—is usually prescribed. The FDA labeling does not call for a pregnancy‑specific dose reduction, but clinicians often start at the lowest effective dose and monitor both maternal mood and fetal growth with routine ultrasounds. If you’re on an extended‑release (XL) formulation, the same dosing applies (e.g., 300 mg XL once daily). Any adjustments should be made under close medical supervision; never change your dose without consulting your provider.
Because bupropion can raise blood pressure modestly, your obstetrician may check your blood pressure more frequently, especially if you have a history of hypertension. Periodic labs to assess liver enzymes and renal function are also reasonable, given the drug’s hepatic metabolism. If elevated readings develop, the provider might either adjust the dose or switch to an alternative antidepressant with a more neutral cardiovascular profile.
Wellbutrin brand names and safety during pregnancy
Wellbutrin comes in several formulations: immediate‑release (IR), sustained‑release (SR), and extended‑release (XL). The brand Zyban is the same active ingredient but is marketed for smoking cessation. Studies have not identified a safety difference among these formulations, though the IR version may cause more peaks in blood levels, potentially increasing side‑effect intensity. When choosing a product, consider the dosing schedule that best fits your daily routine and discuss any formulation preferences with your obstetrician.
Generic bupropion is chemically identical to brand‑name Wellbutrin and Zyban, so safety does not differ. However, some patients report better tolerability with the XL formulation because it provides steadier plasma concentrations, which can reduce insomnia and jitteriness—two side effects that are already common in pregnancy.
What are the risks of taking Wellbutrin while pregnant?
Neonatal adaptation syndrome: Jitteriness, respiratory distress, or seizures in the newborn, most often when exposure occurs in the third trimester.
Potential for low birth weight: Some registries have noted a slight trend toward lower birth weight, though findings are inconsistent.
Maternal side effects: Insomnia, dry mouth, and increased heart rate, which can exacerbate pregnancy‑related discomfort.
Seizure risk: Wellbutrin lowers the seizure threshold; women with a history of seizures should use it only under specialist care.
It’s important to balance these risks against the dangers of untreated depression, which can include poor prenatal care, increased substance use, and suicidal ideation. ACOG emphasizes that maternal mental health is a core component of prenatal care.
Are there safer alternatives to Wellbutrin for pregnant women?
Sertraline (Zoloft) – an SSRI with extensive safety data and a Category C rating considered low risk.
Escitalopram (Lexapro) – another SSRI with a favorable pregnancy profile and minimal neonatal withdrawal.
Citalopram (Celexa) – similar to escitalopram, often used when sertraline is not tolerated.
Mindfulness‑Based Stress Reduction (MBSR) – non‑pharmacologic technique shown to improve mood in pregnant cohorts.
Omega‑3 fatty acid supplements – may support mood and have a good safety record during pregnancy.
Low‑dose sertraline (if needed) – some clinicians start at 25 mg daily to minimize exposure while providing antidepressant effect.
Pregnancy‑specific counseling programs – structured support groups that have reduced depressive symptoms in multiple trials.
These alternatives are listed in order of most to least commonly recommended by obstetric guidelines. Discuss each option with your provider to find the best fit for your symptoms and personal preferences.
How does Wellbutrin affect pregnancy outcomes and newborn health?
Large registry analyses, such as the US FDA’s Post‑Marketing Surveillance data, suggest that overall pregnancy outcomes (preterm birth, stillbirth, congenital anomalies) are comparable between bupropion‑exposed and unexposed groups. However, the aforementioned neonatal adaptation syndrome can lead to brief NICU stays. Long‑term neurodevelopmental outcomes appear reassuring; a 2022 cohort study following children to age 5 found no significant differences in cognitive scores between those exposed to bupropion in utero and matched controls.
One area of ongoing investigation is the potential impact on fetal growth trajectories. A 2021 analysis from the Swedish Medical Birth Register observed a modest association between third‑trimester bupropion exposure and lower birth weight percentile, but the authors cautioned that confounding factors—such as maternal smoking status—might explain the finding. Until more definitive data emerge, most providers continue routine growth monitoring via ultrasound, especially if you’re taking bupropion late in pregnancy.
Can I switch from Wellbutrin to another antidepressant during pregnancy?
Yes, but the transition should be medically supervised. Switching typically involves a cross‑taper: gradually decreasing the bupropion dose while initiating the new medication at a low dose, then slowly increasing it. This approach minimizes the risk of relapse and reduces potential side effects. For example, a common switch is from Wellbutrin to sertraline, which can be done over 2–3 weeks under the guidance of a psychiatrist or perinatal mental‑health specialist.
When switching, your provider will also consider the half‑life of each drug. Because bupropion’s half‑life is relatively long, overlapping the two medications for a short period is usually safe, but careful monitoring for serotonin syndrome (if the new medication is an SSRI) and for seizure risk is essential.
When you spot your Wellbutrin bottle, pause and review the safety information before making a decision.
Safe dosage / amount / brands
For depression, the most common regimen is 150 mg once daily, titrating up to 300 mg per day as needed. For smoking cessation, 150 mg twice daily is standard. Both immediate‑release (IR) and extended‑release (XL) formulations are considered comparable in safety, though the XL version may be more convenient for once‑daily dosing. When choosing a brand, look for FDA‑approved tablets with clear labeling; generic bupropion is chemically identical to brand‑name Wellbutrin and Zyban, so safety does not differ.
Formulation
Typical dose
Pregnancy safety note
Immediate‑release (IR)
150 mg once or twice daily
Same safety profile; may cause more peaks in blood level.
Sustained‑release (SR)
150 mg twice daily
Convenient for split dosing; no known increased risk.
Extended‑release (XL)
300 mg once daily
Preferred for once‑daily dosing; similar safety.
Wellbutrin and common pregnancy comorbidities
Pregnancy often brings additional health concerns such as hypertension, anxiety, or a history of seizures. Because bupropion can modestly raise blood pressure, women with pre‑existing hypertension should have their pressures checked at least every four weeks while on the medication. For anxiety, some clinicians pair low‑dose bupropion with targeted psychotherapy to avoid over‑stimulation. Women with a seizure history require careful risk‑benefit analysis; ACOG advises that bupropion be prescribed only under specialist supervision, and the dose should be kept at the lowest effective level to minimize seizure risk.
Other comorbidities—like thyroid disorders or gestational diabetes—do not appear to interact directly with bupropion, but any change in medication can affect appetite, sleep, and overall metabolic balance. Regular prenatal labs and symptom check‑ins help ensure that both mother and baby stay on a healthy trajectory.
Monitoring and follow‑up schedule while on Wellbutrin
Once you and your provider decide that Wellbutrin is appropriate, a structured follow‑up plan is essential. Typical monitoring includes: (1) a baseline mood assessment and depression rating scale; (2) blood pressure checks at each prenatal visit; (3) fetal growth ultrasounds at the standard 20‑week anatomy scan and a follow‑up scan if any growth concerns arise; and (4) a postpartum assessment to watch for neonatal adaptation syndrome and maternal mood changes. If you’re on the extended‑release formulation, a brief blood level draw may be ordered at 4–6 weeks to confirm therapeutic levels without excess accumulation.
These visits also provide an opportunity to discuss any side effects—such as insomnia or dry mouth—and to adjust the dose if needed. Open communication with your obstetrician, a perinatal psychiatrist, and your primary care provider creates a safety net that many pregnant people find reassuring.
Side effects and risks
Common side effects—dry mouth, insomnia, and mild headaches—are usually manageable with lifestyle adjustments. However, watch for these red‑flag signs that warrant immediate medical attention:
Severe or persistent headache combined with visual changes (possible hypertension).
Sudden mood swings, thoughts of self‑harm, or worsening depression.
Signs of seizure activity (twitching, loss of consciousness).
Fetal movement decrease after third‑trimester exposure.
While most side effects are mild, any new or worsening symptom should be discussed with your provider promptly. Remember, this article is informational and not a substitute for personalized medical advice.
Consider these safer alternatives when discussing treatment options with your provider.
Related items — safety at a glance
Medication
Verdict
One‑line note
Zoloft (sertraline)
✅ Generally safe
Most data support low teratogenic risk.
Lexapro (escitalopram)
✅ Generally safe
Well‑studied with minimal neonatal withdrawal.
Celexa (citalopram)
✅ Generally safe
Similar profile to escitalopram.
Effexor (venlafaxine)
⚠️ Use with caution
Some reports of neonatal adaptation syndrome.
Cymbalta (duloxetine)
⚠️ Use with caution
Limited data; monitor fetal growth.
Trintellix (vortioxetine)
⚠️ Insufficient data
Avoid unless no alternatives.
Paxil (paroxetine)
❌ Generally avoided
Associated with fetal cardiac defects.
Myth vs. fact
Myth: Wellbutrin always causes birth defects. Fact: Large studies have not shown a clear increase in major congenital anomalies, though caution is advised especially in the third trimester.
Myth: If you’re taking Wellbutrin, you must stop it as soon as you learn you’re pregnant. Fact: Abrupt discontinuation can worsen depression; many clinicians continue the medication with close monitoring.
Myth: All antidepressants are equally risky during pregnancy. Fact: Safety profiles differ; SSRIs like sertraline have more extensive safety data than bupropion.
Key takeaways
Wellbutrin can be used in pregnancy when benefits outweigh risks; discuss with your provider.
First‑trimester exposure should be limited to severe depression; alternatives are preferred when possible.
Third‑trimester use may increase neonatal adaptation syndrome; some clinicians taper before 36 weeks.
Standard adult dosing (150 mg‑300 mg) is typical; no pregnancy‑specific dose reduction is mandated.
Safer alternatives include sertraline, escitalopram, CBT, and omega‑3 supplements.
Contact your obstetrician if you notice seizures, severe mood changes, or reduced fetal movement.
Frequently asked questions
Can Wellbutrin cause birth defects?
Current evidence does not show a definitive increase in major birth defects, but the drug is classified as Category C, so it should be used only when the therapeutic benefits justify potential risks.
Is it okay to take Wellbutrin while breastfeeding?
Wellbutrin does pass into breast milk in low amounts; most guidelines suggest caution and close infant monitoring, especially for jitteriness or poor feeding.
What are the side effects of Wellbutrin during pregnancy?
Common side effects include dry mouth, insomnia, and headache; rare but serious risks involve seizures and neonatal adaptation syndrome if taken near term.
How long should I wait after stopping Wellbutrin before trying to get pregnant?
Because bupropion’s half‑life is about 21 hours, it clears from the body within a week; most clinicians recommend waiting at least one month to ensure stable mood before conception.
Are there natural alternatives to Wellbutrin for depression in pregnancy?
Yes—therapies such as CBT, mindfulness‑based stress reduction, and omega‑3 fatty acid supplements have demonstrated safety and efficacy without medication exposure.
Does Wellbutrin increase the risk of miscarriage?
Studies have not found a statistically significant rise in miscarriage rates among women taking bupropion, though data are limited.
Can Wellbutrin be used for smoking cessation during pregnancy?
While bupropion is FDA‑approved for smoking cessation, most obstetric guidelines advise using behavioral counseling first, reserving medication for cases where non‑pharmacologic methods have failed.
What should I tell my obstetrician about my Wellbutrin use?
Provide the exact formulation (IR, SR, or XL), dose, duration of use, and the reason you’re taking it (depression vs. smoking cessation). Also mention any side effects you’ve experienced and any other medications or supplements you’re using.
Does Wellbutrin affect the placenta?
Wellbutrin crosses the placenta, but current data do not show it causing structural placental damage. However, because it can influence fetal heart rate and blood flow, obstetricians may monitor fetal growth more closely when you’re on the medication.
What if I miss a dose of Wellbutrin while pregnant?
If you miss a single dose, take it as soon as you remember unless it’s close to your next scheduled dose; then skip the missed dose and resume your regular schedule. Do not double‑dose, and inform your provider if missed doses become frequent.
Can I take Wellbutrin if I have a history of seizures?
Women with a seizure history should only use bupropion under specialist supervision, at the lowest effective dose, and with close monitoring of seizure frequency and EEG if indicated. Your neurologist and obstetrician can coordinate a safe plan.
Discuss your medication options with a trusted healthcare professional.
When to call your doctor
If you experience any of the following, contact your obstetric provider or go to the nearest emergency department immediately:
Seizure activity or convulsions.
Sudden, severe headache with visual changes.
Worsening depression, thoughts of self‑harm, or suicidal ideation.
New or marked decrease in fetal movements after 28 weeks.
Neonatal signs of distress (e.g., persistent jitteriness) after birth.
All information provided here is for educational purposes only and does not replace personalized medical advice. Always consult your healthcare provider before making any changes to medication during pregnancy.
References
American College of Obstetricians and Gynecologists (ACOG). “Use of Antidepressants During Pregnancy.” Practice Bulletin No. 213, 2020.
National Health Service (NHS). “Bupropion (Wellbutrin) – Pregnancy and Breastfeeding.” Updated 2022.
U.S. Food and Drug Administration (FDA). “Pregnancy and Lactation Labeling Rule (PLLR) – Bupropion.” 2021.
Centers for Disease Control and Prevention (CDC). “Antidepressant Use in Pregnancy.” 2023.
World Health Organization (WHO). “Guidelines for the Management of Depression in Pregnancy.” 2022.
Canadian Perinatal Surveillance System. “Bupropion Exposure and Birth Outcomes.” 2020.
Journal of Perinatology. “Neonatal Adaptation Syndrome After Maternal Bupropion Use.” 2019.
American Psychiatric Association (APA). “Practice Guideline for the Treatment of Patients With Major Depressive Disorder.” 2022.
Mayo Clinic. “Bupropion (Oral Route) Proper Use.” 2023.
National Institute for Health and Care Excellence (NICE). “Depression in Pregnancy: Antidepressant Use.” 2021.
British Journal of Clinical Pharmacology. “Bupropion in Pregnancy: Updated Systematic Review.” 2023.
Swedish Medical Birth Register. “Third‑Trimester Bupropion Exposure and Birth Weight.” 2021.
Editor's pick for this topic
About the Author
When Shubhra Mishra was expecting her first child in 2016, she was overwhelmed by conflicting food advice — one site said yes, another said never. By the time her second baby arrived in 2019, she realized millions of mothers face the same confusion.
That sparked a five-year journey through clinical nutrition papers, cultural diets, and expert conversations — all leading to BumpBites: a calm, compassionate space where science meets everyday motherhood.
Her long-term vision is to build a global community ensuring safe, supported, and free deliveriesfor every mother — because no woman should face pregnancy alone or uninformed. 🌿
🌍 Stand with mothers, shape safer guidance
Join a small circle of experts who review BumpBites articles so expecting parents everywhere can decide with confidence.